State Street Corp Gh Research PLC Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$7.88 - $12.74 $1,512 - $2,446
-192 Reduced 1.76%
10,704 $127,000
Q1 2023

May 15, 2023
SELL
$6.02 - $10.92 $288 - $524
-48 Reduced 0.44%
10,896 $87,000
Q4 2022

Feb 14, 2023
BUY
$9.2 - $13.5 $441 - $648
48 Added 0.44%
10,944 $106,000
Q3 2022

Nov 15, 2022
BUY
$10.15 - $16.15 $110,594 - $175,970
10,896 New
10,896 $127,000

Others Institutions Holding GHRS

# of Institutions
34
Shares Held
23.5M
Call Options Held
63.1K
Put Options Held
1.9K
View Full List

About GH Research PLC

GHRS Quotes by TradingView
  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $433M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email